Dier Mardi's Form 4 filing
Madrigal Pharmaceuticals, Inc. (MDGL) · filed Dec 3, 2025
- Accession no.
- 0001628280-25-055164
- Filed
- Dec 3, 2025
- Trade date
- Dec 2, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 16 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.41M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dier MardiCIK 0001574591 | Officer (EVP and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Common Stock | MOption exerciseAcquired | +4,173 | $251.63 | +$1,050,051.99 | 14,613 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −320 | $570.39 | −$182,524.8 | 14,293 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −410 | $571.99 | −$234,515.9 | 13,883 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −354 | $573.02 | −$202,849.08 | 13,529 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −717 | $574.00 | −$411,558 | 12,812 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −120 | $574.95 | −$68,994 | 12,692 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −240 | $576.15 | −$138,276 | 12,452 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −320 | $577.81 | −$184,899.2 | 12,132 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −258 | $578.83 | −$149,338.14 | 11,874 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −480 | $579.85 | −$278,328 | 11,394 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −240 | $585.44 | −$140,505.6 | 11,154 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −240 | $587.85 | −$141,084 | 10,914 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −160 | $589.65 | −$94,344 | 10,754 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −160 | $590.37 | −$94,459.2 | 10,594 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −74 | $595.20 | −$44,044.8 | 10,520 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −80 | $596.19 | −$47,695.2 | 10,440 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Common Stock | MOption exerciseDisposed | −4,173 | $0.00 | $0 | 9,180 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.